NCT03076060 (Ketomig) is a NA clinical trial of Ketogenic diet in Migraine, sponsored by University of Roma La Sapienza.

Who is sponsoring NCT03076060?

NCT03076060 is sponsored by University of Roma La Sapienza.

What drugs are being tested in NCT03076060?

Interventions in NCT03076060: Ketogenic diet, Sham Diet.

What condition does NCT03076060 study?

NCT03076060 studies Migraine, Overweight and Obesity.

Is NCT03076060 still recruiting?

NCT03076060 is currently completed. Last updated 26 October 2017.

Last reviewed 2017-10-26 · How we verify

NCT03076060: Ketomig

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Very Low Calories Ketogenic Diet in Migraine.

Completed NA Last updated 26 October 2017

What this trial tests

NA trial testing Ketogenic diet in Migraine in 35 participants. Completed in 23 October 2017.

Timeline

1 January 2017

Primary endpoint
1 September 2017

23 October 2017

Quick facts

Lead sponsor	University of Roma La Sapienza
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	quadruple
Primary purpose	treatment
Enrollment	35
Start date	1 January 2017
Primary completion	1 September 2017
Estimated completion	23 October 2017
Sites	1 location across Italy

Drugs / interventions tested

Ketogenic diet — full drug profile →
Sham Diet

Conditions studied

Migraine — all drugs for Migraine →
Overweight and Obesity — all drugs for Overweight and Obesity →

Sponsor

University of Roma La Sapienza

Who can join

Adults 18 to 65, any sex, with Migraine or Overweight and Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Ketogenesis is a physiologic phenomenon due to starvation or ketogenic diet (KD), a drastic restricted carbohydrate dietary regimen that induces lipid metabolism and ketone body (KB) synthesis. We followed, in a dietician clinical setting, a group of migraineurs who randomly received a one-month prescription of experimental diet, followed by a one-month of carbohydrate progressive reintroduction, then another one-month of experimental diet, followed by a one-month of carbohydrate progressive reintroduction. Experimental diets are a very-low calorie KD, or an isocaloric non-ketogenic diet. Aim of our study is verify if during ketogenesis migraine improves.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A Randomized Double-Blind, Cross-Over Trial of very Low-Calorie Diet in Overweight Migraine Patients: A Possible Role for Ketones?
Di Lorenzo C, Pinto A, Ienca R, Coppola G, et al · · 2019 · cited 58× · PMID 31357685 · DOI 10.3390/nu11081742

Verify or expand the search:

Other trials of Ketogenic diet

Trials testing the same drug.

NCT07495267 — Nutritional Ketosis Marfan · NA · not yet recruiting
NCT07415590 — Ketogenic Diet for Post-Traumatic Stress Disorder (PTSD) · NA · not yet recruiting
NCT03991897 — Nutritional Ketosis: a Novel Metabolic Strategy to Treat Lymphedema Patients? · NA · recruiting
NCT07479095 — Low-glucose/High-fat Intake Dietary Regimen as a Tool for Empowering Diagnostic Accuracy of 2-[18F]FDG PET/CT in Lepidic · NA · recruiting
NCT06963437 — Interventions for Weight Regain After Bariatric Surgery · NA · completed

Other recruiting trials for Migraine

Currently open trials in the same condition.

NCT07419607 — MIGRAFIT: Evaluating a Group Therapy Program Combining Physical Activity, Progressive Muscle Relaxation and Psychoeducat · NA · recruiting
NCT07487701 — Migraine Prevention With the Remote Electrical Neuromodulation (REN) Wearable: A Real-world Evidence Study · NA · active not recruiting
NCT07343427 — Impact of GON PRF on Central Sensitization in Migraine Patients · NA · active not recruiting
NCT07336056 — Nerivio Efficacy Under High-Frequency Use · Phase 4 · active not recruiting
NCT07385755 — Desvenlafaxine for Preventive Treatment of Frequent Migraines · NA · active not recruiting

Other University of Roma La Sapienza trials

Trials by the same sponsor.

NCT07485023 — Oral Versus Intravenous Iron for Anemia Diagnosed After 34 Weeks of Gestation · NA · not yet recruiting
NCT07305519 — The Combined Effect of Magnesium, Palmitoylethanolamide, High-Molecular-weight Hyaluronic Acid, Vitamin B6, and Vitamin · NA · not yet recruiting
NCT07520968 — ABX Versus CHX in NSPT: a RCT · NA · active not recruiting
NCT07109596 — Integration of Clinical, Biological and Psycho-social Variables for a Gender-sensitive Frailty Prediction · recruiting
NCT07490574 — Trial of Underwater Versus Gas-Insufflation Colorectal Endoscopic Submucosal DisseEtion · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03076060 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Roma La Sapienza
Last refreshed: 26 October 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03076060.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing